B-Cell CLL/lymphoma 7A (BCL7A) Peptide
BCL7A
Reactivity: Human
Host: Synthetic
BP, BI
Catalog No. ABIN5686038
Quick Overview for B-Cell CLL/lymphoma 7A (BCL7A) Peptide (ABIN5686038)
Target
BCL7A
(B-Cell CLL/lymphoma 7A (BCL7A))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Characteristics
- BCL7A peptide corresponds to 13 amino acids of BCL7A.
-
-
B-Cell CLL/lymphoma 7A (BCL7A) peptide
BCL7A Reactivity: Human, Cow, Dog, Mouse, Pig, Rat Host: Synthetic BP, Imm
-
-
Application Notes
- BCL7A Peptide is used for blocking the activity of BCL7A antibody . The BCL7A antibody ships at 0.5 mg/mL and the BCL7A Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- BCL7A peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
You are here:
